{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:16:53Z","timestamp":1791253013892,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1136\/ard.2010.139949","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T02:12:00Z","timestamp":1292983920000},"page":"831-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Interferon \u03b2 is associated with type 1 interferon-inducible gene expression in dermatomyositis"],"prefix":"10.1016","volume":"70","author":[{"given":"Anne P","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Salajegheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remedios","family":"Nazareno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Kagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G","family":"Jubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2010.139949_bib1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis.","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1136\/ard.2010.139949_bib2","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.139949_bib3","first-page":"S12","article-title":"Genomic analyses identify lipid metabolism abnormalities in dermatomyositis patients.","volume":"127","author":"Kea","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1136\/ard.2010.139949_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy.","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1136\/ard.2010.139949_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1136\/ard.2010.139949_bib6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies.","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1136\/ard.2010.139949_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1373\/clinchem.2004.042523","article-title":"A radical approach is needed to eliminate interference from endogenous antibodies in immunoassays.","volume":"51","author":"Ismail","year":"2005","journal-title":"Clin Chem"},{"key":"10.1136\/ard.2010.139949_bib8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1126\/science.6166984","article-title":"Human lupus inclusions and interferon.","volume":"213","author":"Rich","year":"1981","journal-title":"Science"},{"key":"10.1136\/ard.2010.139949_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(83)91771-3","article-title":"Immune interferon does not stimulate formation of alpha and beta interferon induced human lupus-type inclusions.","volume":"1","author":"Rich","year":"1983","journal-title":"Lancet"},{"key":"10.1136\/ard.2010.139949_bib10","first-page":"584","article-title":"Cultured human endothelial cells treated with recombinant leukocyte A interferon. Tubuloreticular inclusion formation, antiproliferative effect and 2\u2032,5\u2032 oligoadenylate synthetase induction.","volume":"58","author":"Feldman","year":"1988","journal-title":"Lab Invest"},{"key":"10.1136\/ard.2010.139949_bib11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/WCO.0b013e3283311ddf","article-title":"Inflammatory myopathies: disease mechanisms.","volume":"22","author":"Greenberg","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"10.1136\/ard.2010.139949_bib12","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.22558","article-title":"Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis.","volume":"56","author":"Lopez de Padilla","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.139949_bib13","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/art.24555","article-title":"Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy.","volume":"60","author":"Niewold","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.139949_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/107999099313901","article-title":"Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta.","volume":"19","author":"Jabs","year":"1999","journal-title":"J Interferon Cytokine Res"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724145852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724145852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.139949","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T11:24:19Z","timestamp":1736076259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724145852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0003496724145852"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.139949","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon \u03b2 is associated with type 1 interferon-inducible gene expression in dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.139949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/group.bmj.com\/group\/rights-licensing\/permissions. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}